Escolar Documentos
Profissional Documentos
Cultura Documentos
Antagonists
Nur Hesti Kusumasari, dr
Opioid Analgesics
Classification :
Spectrum of Clinical Uses :
Analgesics
Antitussive
Antidiarrheal drugs
Strength of Analgesia :
Strong analgesia
Moderate analgesia
Weak Analgesia
Pharmacokinetics
Most drugs are well absorbed orally
& can be given parenterally
Opioid drugs are widely distributed
to body tissues
They cross the placental barrier &
exert effects on the fetus
The opioid are metabolized by
hepatic enzymes
Mechanism of action
Interaction with specific opioid receptors in the
CNS & peripheral tissues
Three major opioid receptors are , ,
& receptor : contributed to analgesia,
respiratory depression, physical dependence
receptor : contributed to spinal analgesia &
sedative effects of opioid drugs
Opioid receptors are thought to be activated by
endogenous peptides under physiologic
conditions.
these peptides are enkephalins, dynorphin,
beta-endorphin
Ionic mechanisms
The Effects
Acute Effects
Analgesia :
Respiratory depression :
Antitussive actions :
The Effects
Nausea & vomitus
Gastrointestinal effects :
Smooth muscle :
Miosis :
The Effects
Chronic Effects
Tolerance
Physical dependence
Clinical Uses
Analgesia
Cough suppression
Treatment of diarrhea
Anesthesia
Opioid dependence
Toxicity
Overdose
Coma with marked respiratory deppression
& hypotension
Treatment : naloxone, ventilatory support
Drug interactions
Interaction with ethanol, sedative hypnotic,
anesthetic, antipsychotics drugs, tricyclic
antidepressants, & antihistamine (additive
CNS deppression)
Mixed agonist-antagonists
& Partial Agonist drugs
Mixed agonist-antagonists drugs :
Prototype : butorphanol, nalbuphine,
pentazocine
Are agonists with weak
antagonists activity
Partial Agonists drugs :
Prototype : buprenorphine
Is a partial agonists at receptor
Mixed agonist-antagonists
& Partial Agonist drugs
Effects :
Sedation at analgesic doses
Dizzines, sweating, nausea, anxiety,
hallucinations, nightmares
Less intense respiratory deppression
than with pure agonists
Less tolerance
Less physical dependence
Opioid Antagonists
Prototype : naloxone (duration
of action 1-2h), naltrexone (2448h)
Clinical uses : management of
acute opioid overdose
Given intravenously